By many standards, UCSF’s Program for Breakthrough Biomedical Research (PBBR) is small: Its grants represent one-half of 1 percent of the overall research budget at UC San Francisco.
Chancellor Desmond-Hellmann has outlined five key priorities to guide UCSF in its pursuit of continued excellence. Read more
UCSF Medical Center and its health care professionals are consistently ranked among the nation’s best. When a patient needs complex treatment, UCSF is the place to go.
UCSF Chancellor Susan Desmond-Hellmann and her leadership team developed a three-year action plan with a vision for UCSF to become the world's preeminent health sciences innovator and five goals.
Read more
In her third year as Chancellor, Susan Desmond-Hellmann unveiled an action plan for UCSF that builds on its meritorious mission of advancing health worldwide.
Read more
“My vision for UCSF is that we are the world’s preeminent health sciences innovator,” Chancellor Susan Desmond-Hellmann said during her State of the University address on Oct. 4, 2011.
Read more
In her recent appearance at TEDMED, Desmond-Hellmann shared lessons from her career as a practicing oncologist, head of product development at Genentech and the leader of a top university educating the next generation of clinicians in a 15-minute talk.
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, joined Francis Collins, MD, PhD, director of the National Institutes of Health, and Peggy Hamburg, MD, commissioner of the Food and Drug Administration, to talk about precision medicine in the lead up to the OME Precision Medicine Summit at UCSF.
The pharmaceutical industry gets a bad rap for having a corrupting influence on clinical trials, but that perception undermines the many scientific breakthroughs that have come from industry-backed research, according to UC San Francisco’s chancellor.